Sample Analysis - empagliflozin vs metformin in PCOS study

• Research type

  Research Study

• Full title

  Analysis of surplus blood samples from the effect of empagliflozin versus metformin on hormonal, metabolic and cardiovascular risk factors in patients with polycystic ovary syndrome (PCOS) – a randomised open-label parallel study.

• IRAS ID

  251244

• Contact name

  Thozhukat Sathyapalan

• Contact email

  thozhukat.sathyapalan@hey.nhs.uk

• Sponsor organisation

  Research & Development Department, Hull & East Yorkshire Hospitals NHS Trust

• Clinicaltrials.gov Identifier

  N/A, N/A

• Duration of Study in the UK

  0 years, 11 months, 1 days

• Research summary

  We have completed a randomised controlled study comparing the effect of empagliflozin and metformin in women with PCOS. We would like to send unused anonymised samples to Weill Cornell University, Qatar for analysis of various biomarkers elucidating the mechanism of empagliflozin and metformin in women with PCOS after fully executed material transfer agreement which will enrich the research study

• REC name

  Yorkshire & The Humber - Leeds East Research Ethics Committee

• REC reference

  18/YH/0421

• Date of REC Opinion

  1 Nov 2018

• REC opinion

  Favourable Opinion